Genomic Valley Biotech Ltd. BSE: 539206 | GSM

Genomic Valley Biotech Ltd. Live Share Price Today, Share Analysis and Chart

63.44 0.00 (0.00%)

41.34% Fall from 52W High

1 BSE Volume

BSE 22 Apr, 2025 3:31 PM (IST)

Genomic Valley Biotech Key Metrics

Default
All financials are in INR Cr and price data in INR
VIEW MORE
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Not Eligible
-
Expensive Valuation
13.0 / 100
Technically Neutral
49.0 / 100

Genomic Valley Biotech Ltd. Live Price Chart

Fetching data ...

Genomic Valley Biotech Stock Analysis

Genomic Valley Biotech stock analysis with key metrics, changes, and trends.

Genomic Valley Biotech MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue₹0.17 Cr93.98%negative

Annual Revenue fell 93.98%, in the last year to ₹0.17 Cr. Its sector's average revenue growth for the last fiscal year was 11.87%.

Annual Net Profit₹0.02 Cr97.66%negative

Annual Net Profit fell 97.66% in the last year to ₹0.02 Cr. Its sector's average net profit growth for the last fiscal year was 26.81%.

Price to Earning Ratio50.21-negative

Price to Earning Ratio is 50.21, higher than its sector PE ratio of 40.48.

Stock Price₹63.4483.46%positive

Stock Price rose 83.46% and outperformed its sector by 59.42% in the past year.

Quarterly Revenue₹0.22 Cr464.36%positive

Quarterly Revenue rose 464.36% YoY to ₹0.22 Cr. Its sector's average revenue growth YoY for the quarter was 9.98%.

Quarterly Net profit₹0.16 Cr614.15%positive

Quarterly Net profit rose 614.15% YoY to ₹0.16 Cr. Its sector's average net profit growth YoY for the quarter was 20.25%.

Debt to Equity Ratio0.17-positive

Debt to Equity Ratio of 0.17 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)0.42 %0.42%negative

Return on Equity(ROE) for the last financial year was 0.42%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding0.00 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 0%.

Promoter Share Holding46.78 %-0.05%negative

Promoter Share Holding decreased by 0.05% in the most recent quarter to 46.78%.

Promoter Pledges0.00 %0%positive

Promoter Pledges are zero.

VIEW LESS


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

Annual Report Mar-2024
Annual Report Mar-2023
Annual Report Mar-2022
Annual Report Mar-2021
Annual Report Mar-2020
Annual Report Mar-2019
Annual Report Mar-2018
Annual Report Mar-2017
Annual Report Mar-2016
Annual Report Mar-2015

Genomic Valley Biotech Ltd. - Company Profile

What does Genomic Valley Biotech Ltd. do?

Genomic Valley Biotech, With a dedicated team boasting over 10 years of experience in Next-Generation Sequencing (NGS), oncology, and Artificial Intelligence (AI), tHEY are at the forefront of integrating advanced technologies into biotechnology and healthcare solutions. tHEIR team comprises highly skilled professionals passionate about utilizing their extensive knowledge to drive forward the fields of oncology research and diagnostics.

Website: www.genomicvalley.com

Genomic Valley Biotech Ltd. Management structure

All Gross Remunerations are in INR
Anupam Aditya
Company Secretary, Compliance Officer
1.8 Lac
2024-3-31
Gross Remuneration
Year
YOGESH AGRAWAL
Chief Financial Officer
-
2024-3-31
Gross Remuneration
Year

Genomic Valley Biotech Ltd. Board of directors

All Gross Remunerations are in INR
Anupam Aditya
Company Sec. & Compli. Officer
1.8 Lac
2024
Gross Remuneration
Year
Yogesh Agrawal
CMD & Chief Financial Officer
-
2024
Gross Remuneration
Year
Parul Agrawal
Non Executive Director
-
2024
Gross Remuneration
Year
Ashok Kumar Khattar
Independent Director
-
2024
Gross Remuneration
Year
Satendra Kumar Goyal
Independent Director
-
2024
Gross Remuneration
Year

Genomic Valley Biotech Ltd. - company history

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally. The Company is extensively involved in commercial greenhouse / poly house cultivation of crops. Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer. Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry. The Company identified a cluster of 300 marginal farmers eligible to form a Farmers Producer Company. It already started opening a training centre, imparting training to farmers and agri-entrepreneurs profitably. Separate courses have been designed for Training like the Ladies to develop kitchen gardens or small farms which can fetch them profits by growing fruits and vegetables. Apart from this, the Company is also providing Agri Farming Consultancy to farmers and other clients on case to case basis. The Company is taking up turnkey cultivation projects of its clients on clients land with assured buy back and marketing assurance. And finally when production of vegetables comes, the Company shoulders all responsibilities to sell produce in the market to pay the assured amount to client. The Company is having a commercial plant tissue culture laboratory and has the production capacity of 3 million plants per annum. The Company is in process to do all the documentations for getting started with the operation of the Producer Company.

Genomic Valley Biotech Ltd. FAQ

How is Genomic Valley Biotech Ltd. today?
Genomic Valley Biotech Ltd. today is trading in the red, and is down by 0.00% at 63.44.
Genomic Valley Biotech Ltd. is currently trading down 0.00% on an intraday basis. In the past week the stock rose 5.21%. stock has been up 0.70% in the past quarter and rose 83.46% in the past year. You can view this in the overview section.